Tempus AI shares are trading higher Monday morning. The company announced it has received U.S. Food and Drug Administration ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has received 510 (k) clearance from the U.S. Food and ...

Tempus AI's data and services segment is seeing robust revenue growth, fueled by data licensing. Read why I reiterate my strong bullish rating on TEM stock.

Your Apple Wallet app can hold your credit cards and airline boarding passes, helping you make purchases and board flights quickly and easily. But did you know that ...

ITR Filing: Once the income tax return (ITR) is filed and submitted, many taxpayers wait for their income tax refunds, especially when they paid more income tax than required during their ITR filing.

Investors with a lot of money to spend have taken a bearish stance on Tempus AI TEM. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

Tempus AI experienced a price increase of 32% last month, which can be aligned with the significant developments in their collaboration with Northwestern Medicine. This partnership and the integration ...

Renalytix's kidneyintelX.dkd will be the first test offered in Tempus' portfolio in the chronic kidney disease category, ...

If you pop the occasional 5-milligram melatonin tablet every now and then, you’re not alone. According to the Sleep Foundation, just under one-quarter of adults take melatonin as a sleep aid, and a ...